医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Trescal Launches Its Single Source Calibration Solution Across Australia and New Zealand

2022年04月05日 AM07:00
このエントリーをはてなブックマークに追加


 

MELBOURNE, Australia

Trescal, the global leader in calibration services, today announced the launch of its single source instrumentation solutions throughout Australia and New Zealand. The company regroups five acquisitions: Australasian Calibrating Services, Celemetrix, iPAC Solutions, Mobile Test-n-Cal, and the calibration arm of Sudel Industries. Together, the companies represent 175 experts with laboratories located in Adelaide, Auckland, Brisbane, Melbourne, Perth and Sydney.

Trescal provides precision calibration expertise in every industry, geography and instrument across the world. From a single point of contact, Trescal meets any client need either locally or by sending it to another laboratory within the Trescal network to meet rapid turnaround time. In Australia and New Zealand, Trescal has particular expertise in electrical, force and field calibration as well as high voltage testing.

Chris Body, Director of Trescal Australia and New Zealand: “While our name changes, our tradition for providing high quality and high value calibration and support services remains the same. By regrouping all of our companies under the Trescal umbrella, we strengthen our capabilities and diversify our services to better meet the needs of our clients.”

ABOUT TRESCAL

Trescal is the global leader in calibration services. It offers an array of industries a single-source solution for calibration, measurement, repair, qualification, validation and asset management across the globe. Its technicians and experts carry out accredited and non-accredited services for all measured variables and measuring instruments in all technical domains. Trescal’s 4,100 team members perform more than 3.3 million operations per year, including 27,000 repairs across 150,000 types of instruments and 20,000 brands. To learn more visit trescal.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220404005950/en/

CONTACT

Amélie Janson

Marketing and Communications Director

amelie.janson@trescal.com / +33 (0)6 02 13 33 84

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 米国FDAが武田薬品のタクザイロ®(ラナデルマブ・フライオ)を2歳以上の小児における遺伝性血管性浮腫(HAE)発作の予防薬として承認
  • Award-Winning Data CRO Expands Executive Leadership to Support Company’s Next Stage of Growth
  • Avania Acquires MAXIS, Advancing MedTech Leadership in Pre-Clinical, Regulatory Strategy, and Clinical Expertise
  • Corentec Appoints Michael Son as Executive Vice President
  • Emids Names Sean Narayanan as Chief Executive Officer with Founder Saurabh Sinha to Become Chairman